A number of investors have held a position in this Vancouver company for a very long time, waiting patiently for them to develop their blood-testing technologies. This is an interesting company who have shown very little interest, or skill, in hyping their cause.
Recent events indicate to me that some momentum is building, and rumours of new alliances are creeping out. After spending most of 1996 in a holding pattern around $1.10 +\- $.20 (Canadian), we have recently seen a more consistent support in the $1.50 - 1.65 range.
There have been significant management changes in the last two months.
Is there anyone in the SI forum holding shares in this company who would care to comment? |
